z-logo
open-access-imgOpen Access
Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II
Author(s) -
Devi SenGupta,
Philip J. Norris,
Todd J. Suscovich,
Mina HassanZahraee,
Howell Moffett,
Alicja Trocha,
Rika Draenert,
Philip Goulder,
Robert Binder,
Daniel L. Levey,
Bruce D. Walker,
Pramod K. Srivastava,
Christian Brander
Publication year - 2004
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.173.3.1987
Subject(s) - epitope , mhc class i , antigen processing , immunogenicity , cd8 , ctl* , priming (agriculture) , heat shock protein , t cell , antigen presentation , human leukocyte antigen , biology , cytotoxic t cell , peptide , antigen , virology , major histocompatibility complex , brefeldin a , cross presentation , mhc restriction , immunology , endoplasmic reticulum , immune system , microbiology and biotechnology , biochemistry , in vitro , gene , botany , germination , golgi apparatus
Strong CD4(+) and CD8(+) T cell responses are considered important immune components for controlling HIV infection, and their priming may be central to an effective HIV vaccine. We describe in this study an approach by which multiple CD4(+) and CD8(+) T cell epitopes are processed and presented from an exogenously added HIV-1 Gag-p24 peptide of 32 aa complexed to heat shock protein (HSP) gp96. CD8(+) T cell recognition of the HSP/peptide complex, but not the peptide alone, was inhibited by brefeldin A, suggesting an endoplasmic reticulum-dependent pathway. This is the first report to describe efficient processing and simultaneous presentation of overlapping class I- and class II-restricted epitopes from the same extracellularly added precursor peptide complexed to HSP. Given previous reports of the strong immunogenicity of HSP/peptide complexes, the present data suggest that HSP-complexed peptides containing multiple MHC class I- and class II-restricted epitopes represent potential vaccine candidates for HIV and other viral infections suitable to induce effective CTL memory by simultaneously providing CD4 T cell help.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom